Deciphera Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 47 U.S.-traded ETFs. DCPH has around 5.8M shares in the U.S. ETF market. The largest ETF holder of DCPH is the SPDR S&P Biotech ETF (XBI), with approximately 2.18M shares. Investors may also find of interest that the ETF with the largest allocation to DCPH stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 2.49%. On average, U.S. ETFs allocate 0.15% of DCPH to their portfolios.
Additionally, DCPH is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with DCPH as a holding is the Avantis U.S. Small Cap Equity ETF (AVSC), with a return of --.